EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Trial of SiTes to IncreAse diversity in clinical TriaLs (TOTAL): A study protocol paper

Tenzin Yeshi Wangdak Yuthok, Anny D Rodriguez, Victor Ritter, Erin Rose Cruz, Deidre A Okeke, Farmaan Judge, Nicholas Vesom, Sa Shen, FeiFei Qin, Cati G Brown-Johnson, Latha Palaniappan, Anekwe Onwuanyi und 1 weitere

Contemporary Clinical Trials · 2026

DOI: 10.1016/j.cct.2025.108141 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Contemporary Clinical Trials, 2026. Verfasst von Tenzin Yeshi Wangdak Yuthok und 12 weiteren Autor:innen. Beteiligte Einrichtung: Stanford University, School of Medicine, Cardiovascular Medicine, United States of America. Electronic address: twangdak@stanford.edu. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cultural Diversity, Patient Selection, Clinical Trials as Topic. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Trial Of Sites to Increase Diversity in Clinical Trials (TOTAL) addresses the critical issue of underrepresentation in cardiometabolic clinical trials. Despite existing initiatives, disparities in trial participant racial and ethnic diversity persist, limiting the generalizability of findings and health equity. This study aims to evaluate the effectiveness of three diversity-enhancing recruitment strategies (DERS)-virtual community ambassadors, population-based research registries, and social media ads-compared to usual recruitment methods. A hybrid implementation-effectiveness cluster RCT design will randomize 36 cardiovascular clinical trial sites across the US to one of these 4 arms. The main outcome assessed is the proportion of underrepresented participants pre- and during the intervention. Using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework, the study will assess recruitment effectiveness for historically underrepresented participants. Data collection includes de-identified demographic, screening, and enrollment information analyzed through robust statistical methods, including logistic regression and generalized estimating equations. Qualitative interviews with site teams will provide additional insights into implementation challenges and successes. The study aims to identify the most effective recruitment methods, refine these strategies, and disseminate findings to enhance future clinical trial diversity. The TOTAL study's findings will provide evidence-based recommendations for increasing representation in trials, addressing a long-standing barrier to equitable healthcare innovation. By improving diversity, TOTAL will contribute to the broader goal of ensuring that treatments are effective and safe for all populations, fostering inclusivity in scientific research, and advancing precision medicine. This research is supported by the American Heart Association, underscoring its importance in achieving health equity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCultural DiversityPatient SelectionClinical Trials as TopicHumansEthnicityMinority GroupsRandomized Controlled Trials as TopicRegistriesResearch DesignSocial MediaUnited States

Stichwörter der Autor:innen

CardiometabolicCardiovascular diseaseDiversityHealth equityPrecision health

Autor:innen und Institutionen

  • Stanford University, School of Medicine, Cardiovascular Medicine, United States of America. Electronic address: twangdak@stanford.edu.
  • Morehouse School of Medicine, Department of Public Health Education, United States of America. Electronic address: adrodriguez@msm.edu.
  • Stanford University, School of Medicine, Cardiovascular Medicine, United States of America.
  • Stanford University, School of Medicine, Cardiovascular Medicine, United States of America; Morehouse School of Medicine, Department of Public Health Education, United States of America.
  • Morehouse School of Medicine, Department of Cardiology, United States of America.

Förderung

  • American Heart Association

Zitieren

APA

Wangdak Yuthok, T. Y., Rodriguez, A. D., Ritter, V., Cruz, E. R., Okeke, D. A., Judge, F., Vesom, N., Shen, S., Qin, F., Brown-Johnson, C. G., Palaniappan, L., Onwuanyi, A., & Lewis, E. (2026). Trial of SiTes to IncreAse diversity in clinical TriaLs (TOTAL): A study protocol paper. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2025.108141

Vancouver

Wangdak Yuthok TY, Rodriguez AD, Ritter V, Cruz ER, Okeke DA, Judge F, et al. Trial of SiTes to IncreAse diversity in clinical TriaLs (TOTAL): A study protocol paper. Contemporary Clinical Trials. 2026. doi:10.1016/j.cct.2025.108141

BibTeX
@article{WangdakYuthok2026,
  author = {Wangdak Yuthok, Tenzin Yeshi and Rodriguez, Anny D and Ritter, Victor and Cruz, Erin Rose and Okeke, Deidre A and Judge, Farmaan and Vesom, Nicholas and Shen, Sa and Qin, FeiFei and Brown-Johnson, Cati G and Palaniappan, Latha and Onwuanyi, Anekwe and Lewis, Eldrin},
  title = {Trial of SiTes to IncreAse diversity in clinical TriaLs (TOTAL): A study protocol paper},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  doi = {10.1016/j.cct.2025.108141}
}
Kostenlos starten →